interfering RNAs (siRNAs) to examine the effects of GNMT knockdown on cell proliferation and the cell cycle. In addition, the expression of GNMT protein in UC and RCC tissues was evaluated.
INTRODUCTION AND OBJECTIVES:
We previously reported the essential functions of novel cancer stem-like cells (CSCs) antigen, DNAJB8 and its crucial regulator, heat shock factor 1 (HSF1). DNAJB8 is preferentially expressed in renal CSCs in comparison with non-CSCs and plays an important role in maintenance of stemness in CSCs. On the other hand, HSF1 is reported highly expressed in several origins of cancers. In this study, we analyzed the expression levels of these molecules in human renal cell carcinoma (RCC) and evaluated the relationships with clinical outcomes.
METHODS: We collected RCC samples from 51 patients who underwent radical or partial nephrectomy. Total RNA was extracted from RCC specimens and mRNA expressions of DNAJB8 and HSF1 were measured by real-time PCR. Stratified according to the quantitative estimation of the mRNA, the relationship between clinicopathological data and their expression levels were analyzed.
RESULTS: Mean age was 64.3 years. Male and female patients were 28 and 23, respectively. Clinical stage was as follows; Stage I: 33, II: 5, III: 8, IV: 5. Histopatological findings showed 48 of clear cell carcinomas and 3 of type II papillary RCCs. Fourteen showed no expression of DNAJB8, all of whom provided no recurrences of cancer after nephrectomy compared to 9 cases of recurrence with DNAJB8 expressed RCCs during follow up period (P¼0.05, Log rank test), though no significant association with recurrence was observed by HSF1 expression. DNAJB8 expression was significantly associated with pathological vascular invasion (P¼0.04) and tended to be related to cytological grade (P¼0.09). Infiltrative growth pattern (INF) was not associated with DNAJB8 expression (P¼0.43). HSF1 expression did not affect pathological features.
CONCLUSIONS: CSCs are assumed to contribute on recurrence after curative treatment such as radical surgery or radiotherapy. CSCs antigen DNAJB8 was confirmed to be associated with cancer recurrence and pathological features. DNAJB8 might be a good targeting molecule at RCC patients with high risk of recurrence.
Source of Funding: none Vol. 199, No. 4S, Supplement, Monday, May 21, 2018 THE JOURNAL OF UROLOGY â e1205
